Your prediction
Marinomed Biotech AG Stock
Marinomed Biotech AG took a tumble today and lost -€0.220 (-5.240%).
Our community identified positive and negative aspects for Marinomed Biotech AG stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Marinomed Biotech AG stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of Marinomed Biotech AG in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration